Quick Takeaways
- Aymen Abdalkader Shaibatalhamd filed SCHEDULE 13G/A for CorMedix Inc. COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD).
- Disclosed ownership: 5.8%.
- Date of event: 01 Jan 2026.
Aymen Abdalkader Shaibatalhamd - 01 Jan 2026 SCHEDULE 13G/A Report for CorMedix Inc. COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD)
- Filing Manager
- Aymen Abdalkader Shaibatalhamd
- Reporting Manager
- SHAIBATALHAMD AYMEN ABDALKADER
- Symbol
- CRMD
- Shares outstanding
- 79,310,345 shares
- Disclosed Ownership
- 4,600,000 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 02 Jan 2026, 11:53:22 UTC
- Date of event
- 01 Jan 2026
- Previous filing
- 08 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Aymen Abdalkader Shaibatalhamd disclosed 5.8% ownership in CorMedix Inc. COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) on 01 Jan 2026."
What Changed
- Previous schedule filing date: 08 Aug 2025.
- Current filing was accepted on 02 Jan 2026, 11:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SHAIBATALHAMD AYMEN ABDALKADER | 5.8% | 4,600,000 | 4,600,000 | SHAIBATALHAMD AYMEN ABDALKADER | Individual |